20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
With interest rates at levels not seen in over a decade, the private equity model has entered a new phase—one where operational excellence is no…
Read more
Resilience isn’t a buzzword anymore—it’s the make-or-break factor for portfolio companies navigating today’s volatility. That was the takeaway from the standout panel at the PE…
Read more
Rightsizing an organization is never easy. But, it is a normal process as firms adapt to changing market requirements. More recently, higher interest rates, AI…
Read more
Erhalten Sie jeden Monat Neuigkeiten und wertvolle Perspektiven zu Themen der organisatorischen Effektivität
